| Literature DB >> 35684272 |
Warintorn Ruksiriwanich1,2,3, Chiranan Khantham1, Anurak Muangsanguan1, Chuda Chittasupho1,2, Pornchai Rachtanapun3,4, Kittisak Jantanasakulwong3,4, Yuthana Phimolsiripol3,4, Sarana Rose Sommano2,3,5, Korawan Sringarm2,3,6, Emilia Ferrer7, Francisco J Barba7.
Abstract
In Thai folklore wisdom, shallot (Allium ascalonicum L.) was applied as a traditional herbal medicine for hair growth promotion with no scientific evidence. Androgenetic alopecia (AGA) is a progressive hair loss caused by multiple factors, including androgen hormones, inflammation, and oxidative stress. Conventional medicines (finasteride, dutasteride, corticosteroids, and minoxidil) have been used with limited therapeutic efficacy and unpleasant side effects. In this study, we aimed to give the first estimation of bioactive compounds in shallot extract and evaluate the hair growth-promoting activities regarding anti-inflammatory and gene expression modulation involving androgen, Wnt/β-catenin, sonic hedgehog, and angiogenesis pathways. The results reveal that phenolic compounds (quercetin, rosmarinic, and p-coumaric acids) are the major constituents of the methanolic shallot extract. Compared with the lipopolysaccharide-stimulated control group (2.68 ± 0.13 µM), nitric oxide production was remarkably diminished by shallot extract (0.55 ± 0.06 µM). Shallot extract improves hair growth promotion activity, as reflected by the downregulation of the androgen gene expression (SRD5A1 and SRD5A2) and the upregulation of the genes associated with Wnt/β-catenin (CTNNB1), sonic hedgehog (SHH, SMO, and GIL1), and angiogenesis (VEGF) pathways. These findings disclose the new insights of shallot extract on hair growth promotions. Shallot extract could be further developed as nutraceutical, nutricosmetic, and cosmeceutical preparations for AGA treatment.Entities:
Keywords: 5α-reductase; Allium ascalonicum; SRD5A2; Wnt/β-catenin; androgenetic alopecia; anti-hair loss; anti-inflammatory; hair growth promotion; shallot
Year: 2022 PMID: 35684272 PMCID: PMC9182775 DOI: 10.3390/plants11111499
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Content of bioactive compounds of shallot extract.
| Bioactive Compounds | Content | |
|---|---|---|
| Total polysaccharide content | 0.90 ± 0.06 | mg D-glucose/g |
| Total protein content | 1.01 ± 0.04 | mg BSAE/g |
| Total phenolic content | 4.69 ± 0.42 | mg GAE/g |
| Total flavonoid content | <0.003 | mg EGCGE/g |
| Phenolic compounds | ||
| 1.091 ± 0.011 | mg/g | |
| Quercetin | 0.029 ± 0.002 | mg/g |
| Rosmarinic acid | 0.234 ± 0.007 | mg/g |
Note: Milligrams of gallic acid equivalents per gram of extract (mg GAE/g extract); milligrams of epigallocatechin gallate equivalents per gram of extract (mg EGCGE/g extract); milligrams of D-glucose equivalents per gram of extract (mg D-glucose/g extract); milligrams of bovine serum albumin equivalents per gram of extract (mg BSAE/g extract).
Figure 1Chromatogram of bioactive compounds in shallot extract analyzed by liquid chromatography–mass spectrometry (LC-MS).
Figure 2Cell viability of RAW 264.7 macrophage cells (RAW 264.7), DU-145 human prostate cancer cells (DU-145), and human hair follicle dermal papilla cells (hHFDPC) after shallot extract treatment for 24 h with different concentrations (0.02 to 2.5 mg/mL) was determined by sulforhodamine B (SRB) assay. Different letters (a, b, and c) indicate statistical differences (p-value < 0.05) in the cell viability of each concentration.
Figure 3Effects of shallot extract (SE) and diclofenac sodium (DF) at the same concentration of 0.1 mg/mL on nitrite production in the lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophages for 24 h compared to solvent-treated control without LPS (blank) and LPS-stimulated control (+LPS). Different letters (a and b) indicate statistical significance (p < 0.05) in comparison to +LPS and DF.
Figure 4Effect of shallot extract (SE, 0.1 mg/mL) on expressions of genes associated with androgenetic alopecia: (a) SRD5A1; (b) SRD5A2; (c) SRD5A3; (d) SHH; (e) SMO; (f) GIL1; (g) CTNNB1; (h) VEGF. DU-145 human prostate cancer cells (DU-145) were used to observe the expressions of genes in the androgen pathway (SRD5A genes), whereas human hair follicle dermal papilla cells (hHFDPC) were used to study the remaining pathways. Different letters (a, b, and c) indicate statistical significance (p < 0.05) in comparison to control, finasteride (0.1 mg/mL), dutasteride (0.1 mg/mL), purmorphamine (0.1 mg/mL), and minoxidil (0.1 mg/mL).